Clinical trial
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules
NCT05058040 is registered in ClinicalTrials.gov with Green Valley (Shanghai) Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules
- Lead sponsor
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- June 2, 2021
- Completion date
- April 30, 2025
- Enrollment
- 2,500 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.